semaglutide recombinant synthesis Peptide mapping analysis of synthetic and liraglutide for generic development of drugs originating from DNA technology Commercial manufacturing of current good

semaglutide recombinant synthesis

semaglutide recombinant synthesis Peptide mapping analysis of synthetic and liraglutide for generic development of drugs originating from DNA technology Commercial manufacturing of current good

Name: semaglutide recombinant synthesis Peptide mapping analysis of synthetic and liraglutide for generic development of drugs originating from DNA technology Commercial manufacturing of current good
Brand: www.guttershellne.com
SKU: 51971364132
Price: 26.85 USD
Availability: InStock
Rating: 4.6624 (19 reviews)

SKU: 51971364132

4.7

USD26.85 USD69.85

Pay in 4 interest-free payments of $6.71 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Multiple targets The next generation of GLP-1 drugs is already entering the clinic with a shift to dual and triple agonists

The present application also relates to a recombinant process for the preparation of semapeptide

CULTURE MEDIA C12N2310/00Structure or type of the nucleic acid C12N2310/30Chemical structure C12N2310/35Nature of the modification C12N2310/351Conjugate C12N2310/3517Marker

DNA polymerase was used for the PCR amplification ( Figure 2)